Pharmacist Case Finding and Intervention for Vascular Prevention Trial

Launched by UNIVERSITY OF ALBERTA · May 4, 2024

Keywords

ClinConnect Summary

The Pharmacist Case Finding and Intervention for Vascular Prevention Trial is a research study aimed at helping people reduce their risk of heart disease, a serious condition that affects many individuals around the world. The study is exploring whether pharmacists, who are often the most accessible healthcare providers, can lead efforts to support patients in managing their health better. This could include guidance on lifestyle changes and medication management to lower risks associated with heart disease.

To participate in this trial, individuals must be 18 years or older and have a diagnosis of certain health conditions, such as diabetes, high blood pressure, or obesity. If you decide to join, you can expect regular follow-up visits where the pharmacist will work with you to create a personalized plan for improving your heart health. It’s important to note that pregnant individuals or those who cannot commit to follow-up visits will not be eligible to join. This trial aims to empower participants with knowledge and tools to take charge of their heart health, ultimately benefiting both individuals and the wider community.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults (18 years or older)
• * Clinical diagnosis of at least one of the following conditions:
• • Diabetes,
• • Chronic kidney disease,
• • Chronic inflammatory condition (e.g., rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, gout, systemic lupus erythematosus or psoriasis),
• • Atherosclerotic vascular disease,
• • Hypertension,
• • Obesity (defined as body mass index greater than 30),
• • Current tobacco or vape use
• Exclusion Criteria:
• • Unwilling to participate/sign consent form;
• • Unwilling or unable to participate in regular follow-up visits; or
• • Pregnant